| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $239K | -51.6% |
| SG&A Expense | $425K | -19.5% |
| Operating Income | -$664K | +35.0% |
| Pre-tax Income | -$1.0M | -137.8% |
| Net Income | -$1.0M | -137.8% |
| EPS (Basic) | -$0.03 | -108.6% |
| EPS (Diluted) | -$0.03 | +57.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5K | -99.3% |
| Current Assets | $5K | -99.3% |
| Total Assets | $5K | -99.3% |
| Current Liabilities | $5.2M | -6.8% |
| Total Liabilities | $5.2M | -8.6% |
| Stockholders' Equity | -$5.2M | -4.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$706K | -1.9% |
| Financing Cash Flow | $1.0M | +0.0% |